壳聚糖在纳米药物递送载体领域的应用现状(7)
[41] ABNOOS M,MOHSENI M,MOUSAVI SAJ,et lginate nanocarrier for transdermal delivery of pirfenidone in idiopathic pulmonary J Bio :S1619.
[42] ISLAM MA,PARK TE,REESOR E,et chitosan derivatives as novel drug Pharm Des.2015;21(29):4285-4309.
[43] KUMAR A,VIMAL A,KUMAR A.Why chitosan? From properties to perspective of mucosal drug J Biol ;91:615-622.
[44] ANTER HM,HASHIM IA,AWADIN W,et al.Novel chitosan oligosaccharide -based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”.Int J ;14:4911-4929.
[45] MARTíNEZ-PéREZ B,QUINTANAR-GUERRERO D,TAPIA-TAPIA M,et biodegradable nanoparticles:From preparation to vaginal J Pharm Sci.2018;115:185-195.
[46] SUN M,YU X,WANG T,et al.Nasal adaptive chitosan-based nanovehicles for anti-allergic drug J Bio ; 135:1182-1192.
[47] LEI X,YA-TONG F,TIAN-JIAO Z,et modification of chitosan for efficient vaccine ;23(2):229.
[48] SINANI G,SESSEVMEZ M,KORAY G,et chitosan-based nano adjuvants enhance immunogenicity of protein antigens after mucosal J ;569:.
[49] LAI JY,LUO (N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine J Pharm ;113:140-148.
[50] BOLES LR,BUMGARDNER JD,FUJIWARA T,et of trimethyl chitosan/polyethylene glycol derivatized chitosan blend as an injectable and degradable antimicrobial delivery J Biol ;133:372-381.
[51] CAPRIFICO AE,FOOT PJS,POLYCARPOU E,et the bloodbrain barrier:functionalised chitosan ;12(11):1013.
[52] CORTéS H,ALCALá-ALCALá S,CABALLERO-FLORáN IH,et al.A reevaluation of chitosan-decorated nanoparticles to cross the bloodbrain (Basel).2020;10(9):212.
[53] YAN T,ZHU S,HUI W,et based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and ;250:.
[54] WU D,ZHU L,LI Y,et chitosan nanocomplexes for colorectal tumor-targeted delivery of J ;584:.
文章来源:《电子元件与材料》 网址: http://www.dzyjyclzz.cn/qikandaodu/2021/0708/720.html
上一篇:胶原蛋白肽分析方法及透皮吸收特征
下一篇:开发超常视力凝视未来